Taro Pharmaceutical Industries Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.31 | $0.31 | $0.31 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Taro Pharmaceutical Industries Ltd. Earnings Date And Information
Taro Pharmaceutical Industries Ltd. last posted its earnings results on Monday, May 20th, 2024. The company reported $0.4 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.09. The company had revenue of 164.94 M for the quarter and had revenue of 629.18 M for the year. Taro Pharmaceutical Industries Ltd. has generated $1 earnings per share over the last year ($1.43 diluted earnings per share) and currently has a price-to-earnings ratio of 29.99. Taro Pharmaceutical Industries Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based on prior year's report dates.
Taro Pharmaceutical Industries Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/21/2024 | Q4 2024 | $0.40 | $156.06 M | $164.94 M | ||
| 01/26/2024 | Q3 2024 | $0.54 | $154.91 M | $157.15 M | ||
| 10/27/2023 | Q2 2024 | $0.23 | $148.20 M | |||
| 07/27/2023 | Q1 2024 | $0.27 | $158.89 M | |||
| 05/24/2023 | Q4 2023 | $0.18 | $150.69 M | $146.59 M | ||
| 12/31/2022 | Q3 2023 | $0.19 | $163.12 M | $139.20 M | ||
| 11/09/2022 | Q2 2023 | -$0.07 | $130.50 M | |||
| 07/28/2022 | Q1 2023 | $0.37 | $156.67 M | |||
| 07/25/2022 | Q4 2022 | $0.73 | $147.00 M | $143.26 M | ||
| 12/30/2021 | Q3 2022 | $0.70 | $142.20 M | $138.98 M | ||
| 09/29/2021 | Q2 2022 | $0.62 | $131.99 M | |||
| 06/29/2021 | Q1 2022 | -$0.50 | $147.11 M | |||
| 06/17/2021 | Q4 2021 | -$0.78 | $147.33 M | $148.35 M | ||
| 12/30/2020 | Q3 2021 | $0.86 | $152.63 M | $140.15 M | ||
| 09/29/2020 | Q2 2021 | $1.18 | $142.84 M | |||
| 07/23/2020 | Q1 2021 | -$11.37 | $117.63 M | |||
| 06/19/2020 | Q4 2020 | $1.42 | $168.25 M | $174.94 M | ||
| 01/10/2020 | Q3 2020 | $1.76 | $172.01 M | $147.68 M | ||
| 11/04/2019 | Q2 2020 | $1.72 | $1.46 | -0.26 | $160.85 M | |
| 06/29/2019 | Q1 2020 | $1.72 | $161.30 M |
Taro Pharmaceutical Industries Ltd. Earnings: Frequently Asked Questions
-
When is Taro Pharmaceutical Industries Ltd.'s earnings date?
Taro Pharmaceutical Industries Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off last year's report dates.
-
Did Taro Pharmaceutical Industries Ltd. beat their earnings estimates last quarter?
In the previous quarter, Taro Pharmaceutical Industries Ltd. (:TARO) reported $0.4 earnings per share (EPS) to beat the analysts' consensus estimate of $0.31 by $0.09.
-
How can I listen to Taro Pharmaceutical Industries Ltd.'s earnings conference call?
The conference call for Taro Pharmaceutical Industries Ltd.'s latest earnings report can be listened to online.
-
How can I read Taro Pharmaceutical Industries Ltd.'s conference call transcript?
The conference call transcript for Taro Pharmaceutical Industries Ltd.'s latest earnings report can be read online.
-
How much revenue does Taro Pharmaceutical Industries Ltd. generate each year?
Taro Pharmaceutical Industries Ltd. (:TARO) has a recorded annual revenue of $629.18 M.
-
How much profit does Taro Pharmaceutical Industries Ltd. generate each year?
Taro Pharmaceutical Industries Ltd. (:TARO) has a recorded net income of $629.18 M. Taro Pharmaceutical Industries Ltd. has generated $1.43 earnings per share over the last four quarters.
-
What is Taro Pharmaceutical Industries Ltd.'s price-to-earnings ratio?
Taro Pharmaceutical Industries Ltd. (:TARO) has a price-to-earnings ratio of 29.99 and price/earnings-to-growth ratio is 1.66.
